← Leaderboards
Eric Peter Schmidt
Johns Hopkins University
$6,656,755
Attributed
$11,792,652
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2007–25$2.5M$1.9M$1.3M$625K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,792,652 · 10
By mechanism
R01$9,847,721 · 5
R33$675,868 · 1
K08$643,655 · 1
R21$479,820 · 1
F32$115,588 · 1
R13$30,000 · 1
Top collaborators
- Paco S Herson8 shared
- Nathan I Shapiro7 shared
- Robert J Linhardt5 shared
- David W Riches1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Shanthini Sockanathan$12,143,558
- King-Wai Yau$28,664,002
- David Sidransky$59,922,938
- David Alan Kass$45,555,857
- Steven Herbert Abman$28,175,515
Others in their field
Top investigators on “Functional Disorder”
- Randall J Bateman · Washington University$164,791,794
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- David Heimbrook · Leidos Biomedical Research, Inc.$127,725,513
- Ed Lein · Allen Institute$92,850,604
- Beth Baseler · Leidos Biomedical Research, Inc.$87,027,148
- John M Lachin · George Washington University$85,958,868
Research focus
Functional DisorderBlood VesselsGlycocalyxSepsisGlycosaminoglycansEndotheliumInvestigationSugarResponseHeparitin SulfateLaboratoriesInjurySepticMediatingInfectionLungPreventLipopolysaccharidesCollaborationsCritical IllnessMouse ModelLiquid SubstanceBaseEndothelial Cells
Grant awards (29)
Alveolar epithelial glycocalyx resilience in women during ARDS$761,615
R01 · FY2025 · HL · contact PI
Vascular mechanisms of sepsis-induced cognitive dysfunction$696,071
R01 · FY2025 · HL
Optimization of a rapid assay to quantify circulating glycosaminoglycans and identify vascular endotypes of sepsis$675,868
R33 · FY2025 · GM · contact PI
Vascular mechanisms of sepsis-induced cognitive dysfunction$682,150
R01 · FY2024 · HL
Optimization of a rapid assay to quantify circulating glycosaminoglycans and identify vascular endotypes of sepsis$231,535
R21 · FY2024 · GM · contact PI
Vascular mechanisms of sepsis-induced cognitive dysfunction$726,968
R01 · FY2023 · HL
Optimization of a rapid assay to quantify circulating glycosaminoglycans and identify vascular endotypes of sepsis$248,285
R21 · FY2023 · GM · contact PI
The Impact of Fluid Resuscitation on Glycocalyx Degradation in Septic Shock$378,727
R01 · FY2022 · HL
The Impact of Fluid Resuscitation on Glycocalyx Degradation in Septic Shock$398,769
R01 · FY2021 · HL
Targeting circulating endothelial glycocalyx fragments to reduce septic encephalopathy$438,956
R01 · FY2020 · GM · contact PI
The Impact of Fluid Resuscitation on Glycocalyx Degradation in Septic Shock$414,860
R01 · FY2020 · HL
ARDS in the 21st Century: New Insights into Clinical and Mechanistic Heterogeneity$30,000
R13 · FY2020 · HL · contact PI
The Impact of Fluid Resuscitation on Glycocalyx Degradation in Septic Shock$490,378
R01 · FY2019 · HL
Targeting circulating endothelial glycocalyx fragments to reduce septic encephalopathy$441,651
R01 · FY2019 · GM · contact PI
Targeting circulating endothelial glycocalyx fragments to reduce septic encephalopathy$139,824
R01 · FY2019 · GM · contact PI
Endothelial glycocalyx reconstitution during sepsis$663,178
R01 · FY2018 · HL · contact PI
Targeting circulating endothelial glycocalyx fragments to reduce septic encephalopathy$446,852
R01 · FY2018 · GM · contact PI
Endothelial glycocalyx reconstitution during sepsis$664,880
R01 · FY2017 · HL · contact PI
Targeting circulating endothelial glycocalyx fragments to reduce septic encephalopathy$480,646
R01 · FY2017 · GM · contact PI
Endothelial glycocalyx reconstitution during sepsis$666,703
R01 · FY2016 · HL · contact PI
Endothelial glycocalyx reconstitution during sepsis$658,461
R01 · FY2015 · HL · contact PI
Pulmonary endothelial glycocalyx degradation causes ARDS during sepsis$128,331
K08 · FY2015 · HL · contact PI
Endothelial glycocalyx reconstitution during sepsis$697,032
R01 · FY2014 · HL · contact PI
Pulmonary endothelial glycocalyx degradation causes ARDS during sepsis$128,331
K08 · FY2014 · HL · contact PI
Pulmonary endothelial glycocalyx degradation causes ARDS during sepsis$128,331
K08 · FY2013 · HL · contact PI
Pulmonary endothelial glycocalyx degradation causes ARDS during sepsis$128,331
K08 · FY2012 · HL · contact PI
Pulmonary endothelial glycocalyx degradation causes ARDS during sepsis$130,331
K08 · FY2011 · HL · contact PI
cGMP Compartmentalization in Pulmonary Endothelial Barrier Dysfunction$58,886
F32 · FY2008 · HL · contact PI
cGMP Compartmentalization in Pulmonary Endothelial Barrier Dysfunction$56,702
F32 · FY2007 · HL · contact PI